Ładuje się......
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir
December 2019 saw the emergence of a new epidemic of pneumonia of varying severity, called COVID-19, caused by a newly identified coronavirus, SARS-CoV-2. No therapeutic option is available to treat this infection that has already killed more than 235,000 people worldwide. This Viewpoint summarizes...
Zapisane w:
| Wydane w: | Clin Infect Dis |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Oxford University Press
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239253/ https://ncbi.nlm.nih.gov/pubmed/32409832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa587 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|